Perha Pharmaceuticals
PrivateLast Round
Grant
Mar 23, 2022
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Perha Pharmaceuticals operates in Healthcare & Life Sciences and is based in Roscoff. It was founded in 2019.
Perha Pharmaceuticals is a biotechnology company that develops small-molecule kinase inhibitors derived from natural marine products for the treatment of cognitive disorders and the prevention of hearing loss.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Perha Pharmaceuticals Comparables
Compare Perha Pharmaceuticals with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Pharmasum Therapeutics | 89% | |
| Iluminos Therapeutics LLC | 81% | |
| Connecta Therapeutics | 79% |
For institutional investors. Book with your work email.
Perha Pharmaceuticals Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Mar 23, 2022 | ||||
| VC Round | Mar 23, 2022 |
For institutional investors. Book with your work email.
Perha Pharmaceuticals Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| European Innovation Council Fund | Grant, VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 24, 2026
Monthly visitors grew 149% MoM, from 431 to 1.1K.
- Apr 16, 2026
Monthly visitors increased 53% MoM.
For institutional investors. Book with your work email.
Perha Pharmaceuticals Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Perha Pharmaceuticals's valuation, stock price, and market status.
Is Perha Pharmaceuticals a public or private company?
Perha Pharmaceuticals is a private company.
What is the current stock price of Perha Pharmaceuticals?
Perha Pharmaceuticals is a private company, so its shares have no public market price. Caplight tracks Perha Pharmaceuticals's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Perha Pharmaceuticals worth (valuation)?
Valuation information for Perha Pharmaceuticals is not publicly available.
Can I buy Perha Pharmaceuticals stock?
Perha Pharmaceuticals shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Perha Pharmaceuticals's last funding round?
Perha Pharmaceuticals's most recent funding round was Grant on March 23, 2022.
Who are the main investors in Perha Pharmaceuticals?
Key investors in Perha Pharmaceuticals include European Innovation Council Fund.
Will Perha Pharmaceuticals IPO soon?
No public IPO plans have been announced for Perha Pharmaceuticals.
How can I track Perha Pharmaceuticals secondary market activity?
Caplight tracks bids, offers, and trades in Perha Pharmaceuticals's shares on secondary markets.